A single focused day of clinical learning delivered by invited faculty, with a pre-conference symposium on the evening before.
The programme is correct at the time of publication and may be subject to minor adjustments. The final programme will be confirmed in the Final Announcement.
Friday, 25 September 2026
Saturday, 26 September 2026
A single focused day of clinical learning delivered by invited faculty, with a pre-conference symposium on the evening before.
The programme is correct at the time of publication and may be subject to minor adjustments. The final programme will be confirmed in the Final Announcement.
Friday, 25 September 2026
| Time | Session |
|---|---|
| 1830–1915 | Registration |
| 1915–1920 | Welcome |
| 1920–1940 | Singapore IBD Inception Cohort Chairperson: Ling Khoon Lin Speaker: Ennaliza Salazar |
| 1940–2020 | Dinner Symposium (Educational Grant from Abbvie) Chairperson: Tey Tze Tong, Ling Khoon Lin Debate: Is it time for advanced therapies for all patients with Crohn’s disease? Propose: Kelvin Thia Oppose: Ida Hilmi |
Saturday, 26 September 2026
| Time | Session | Highlights |
|---|---|---|
| 0830–0900 | Registration | |
| 0900–1000 | IBD Treatment I Chairpersons: Webber Chan & Tony Lim |
Rapid Fire Topics How do we choose between budesonide MMX and enteric coated budesonide capsule for IBD (5 mins) Bernice Tan Can JAKi take the place of steroids in the treatment of acute severe ulcerative colitis (if cost is not a concern) (5 mins) Ida Hilmi Should all colonoscopy reports for IBD include disease activity scores eg Mayo endoscopic subscore or SES CD (5 mins) Tan Chin Kimg What to do with isolated terminal ileal ulcers / inflammation in a patient with loose stools (and who is not known to have Crohn’s disease) (5 min) Yan Zhi Hao Question-and-Answer Session (10 mins) Ulcerative proctitis Ulcerative proctitis: Treatment with oral and topical mesalazine (15 mins) Ennaliza Salazar Is there are a role for advanced therapy for ulcerative proctitis (15 mins) Ooi Choon Jin |
| 1000–1030 | Tea Break | |
| 1030–1225 | What is new in IBD? Chairpersons: Juanda Leo Hartono & Kelvin Thia |
Diagnostic delay in inflammatory bowel disease: initial presentation, associated factors, and impact on surgical outcomes at a tertiary Asian centre (5min) Justin Leong Treat to Target – What is new in STRIDE III (20 mins) Axel Dignass New endoscopic tools for IBD (15 mins) Raymond Liang Intestinal ultrasound (30 mins) What can IUS do in the diagnosis of IBD Thomson Lim For what indications can non-POC IUS replace colonoscope/MRI/CT Alex Leow New Drugs for IBD (45 mins) IL23 p19 inhibitors Wei Shuchen JAK inhibitors Ling Khoon Lin S1P receptor modulators Lin Huiyu |
| 1225–1240 | Welcome Address Chairperson: David Ong |
By President of SG-IBD Ooi Choon Jin By President of GESS Kieron Lim |
| 1240–1350 | Lunch Break | Lunch Symposium (40 min) Treatment of perianal Crohn’s disease Axel Dignass Exhibitis |
| 1350–1515 | IBD Treatment II Chairpersons: Pang Shu Kuan & Christopher Kong |
Free paper – Acute Severe Ulcerative Colitis (ASUC) Management in a Southeast Asian Tertiary Hospital: Low Prognostic Scores but High Rescue Therapy Use (5min) Jonathan Koh Positioning and sequencing of advanced therapies for CD – Case study with discussion (20 mins) Tan Yi Yuan Discussants – Wei Shuchen & Ida Hilmi – Talk (20 min) Malcolm Tan Positioning and sequencing advanced therapies for UC – Case study (20 mins) (dual advanced therapy) Tan Shi Ni Discussants: Julajak Limsrivilai & Alex Leow – Talk (20 mins) Lim Wee Chian |
| 1515–1545 | Tea Break | |
| 1545–1635 | IBD Treatment III Chairpersons: David Ong & Lim Teong Guan |
Free paper – Olink based proteomic profiling identifies early inflammatory-to-neoplastic transition markers in IBD associated colorectal carcinoma (5 mins) |
| 1635–1645 | Closing |